Skip to main navigation

Overview
News & Events
- News Releases
- Events
Stock Information
Financial & Filings
Governance
Responsibility
Investor Resources

News Releases

Year

19 Dec '24

Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal

10 Dec '24

Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy

13 Nov '24

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

07 Nov '24

Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024

31 Oct '24

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

31 Oct '24

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

31 Oct '24

Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

24 Oct '24

Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma

10 Oct '24

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

03 Oct '24

Bionano Adjourns Special Meeting of Stockholders to October 30, 2024

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Next page
Last page

Displaying 1 - 10 of 53

Print Page
Email Alerts
RSS Feeds

Request Email Alerts

© 2024 Bionano Genomics, Inc. All rights reserved. For Research Use Only. Not For Use In Diagnostic Procedures. | Legal Notice | Privacy Policy